Securities Registration: Employee Benefit Plan (s-8)
April 06 2018 - 4:44PM
Edgar (US Regulatory)
As
filed with the Securities and Exchange Commission on April 6, 2018.
Registration
No. 333-_____
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
S-8
REGISTRATION
STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
OncoSec
Medical Incorporated
(Exact
name of registrant as specified in its charter)
Nevada
|
|
98-0573252
|
(State
or other jurisdiction of
|
|
(I.R.S.
Employer
|
incorporation
or organization)
|
|
Identification
No.)
|
5820
Nancy Ridge Drive
San
Diego, CA 92121
(Address
of Principal Executive Offices)
OncoSec
Medical Incorporated 2011 Stock Incentive Plan
(Full
title of the plan)
Daniel
J. O’Connor
Chief Executive Officer
OncoSec Medical Incorporated
5820 Nancy Ridge Drive
San
Diego, CA 92121
(855)
662-6732
|
With
a copy to:
Matthew
W. Mamak, Esq.
John
B. Shannon, Esq.
Alston & Bird LLP
90 Park Avenue
New York, New York 10016
(212) 210-9400
|
(Name,
address, and telephone number of agent for service)
|
|
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer [ ]
|
|
Accelerated
filer [ ]
|
Non-accelerated
filer [ ]
|
(Do
not check if a smaller reporting company)
|
Smaller
reporting company [X]
|
|
|
Emerging
growth company [ ]
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
[ ]
CALCULATION
OF REGISTRATION FEE
Title of securities to be registered
|
|
Amount to be registered
|
|
|
proposed
maximum
offering price
per share
|
|
|
proposed
maximum
aggregate
offering price
|
|
|
Amount of
registration fee
|
|
Common Stock, $.0001 par value
|
|
|
3,500,000
|
(1)
|
|
$
|
2.13
|
(2)
|
|
$
|
7,455,000.00
|
(2)
|
|
$
|
928.15
|
|
(1)
|
Represents
additional shares of the common stock, par value $0.0001 per share (the “Common Stock”), of OncoSec Medical Incorporated
(the “Registrant”) authorized for issuance under the OncoSec Medical Incorporated 2011 Stock Incentive Plan, as
amended (the “Plan”). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities
Act”), this registration statement on Form S-8 (this “Registration Statement”) shall also cover any additional
securities that may be offered or issued in connection with any stock dividend, stock split, recapitalization or other similar
transaction.
|
|
|
(2)
|
Estimated
solely for the purpose of calculating the registration fee. Pursuant to Rule 457(c) and Rule 457(h) under the Securities Act,
the proposed maximum offering price per share and the proposed maximum aggregate offering price have been determined on the
basis of the average of the high and low prices of the registrant’s common stock reported on the Nasdaq Capital Market
on April 5, 2018.
|
EXPLANATORY
NOTE
This
Registration Statement registers an additional 3,500,000 shares of the Registrant’s Common Stock that may be offered and
sold under the Plan pursuant to an amendment of the Plan approved by the Board of Directors of the Registrant on September 18,
2017 and approved by the Shareholders of the Registrant on January 12, 2018. This Registration Statement relates solely to the
registration of additional securities of the same class as other securities for which one or more other registration statements
filed on this form relating to the same employee benefit plan are effective. Pursuant to General Instruction E. to Form S-8, the
contents of the Registrant’s previously filed registration statements on Form S-8 relating to the Plan (File No. 333-176537,
File No. 333-188726, File No. 333-197678, File No. 333-202752, File No. 333-209948 and File No. 333-218674), filed with the Securities
and Exchange Commission on August 29, 2011, May 21, 2013, July 28, 2014, March 13, 2015, March 4, 2016 and June 12, 2017, respectively,
including any amendments thereto or filings incorporated therein, are hereby incorporated by reference herein to the extent not
otherwise amended or superseded by the contents hereof.
Item
8. Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf
by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on April 6, 2018.
|
OncoSec
Medical Incorporated
|
|
|
|
|
By:
|
/s/
Daniel J. O’Connor
|
|
|
Daniel
J. O’Connor
|
|
|
Chief
Executive Officer
|
Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/
Daniel J. O’Connor
|
|
Chief
Executive Officer (Principal
|
|
April
6, 2018
|
Daniel
J. O’Connor
|
|
Executive
Officer) and Director
|
|
|
|
|
|
|
|
/s/
Richard B. Slansky
|
|
Chief
Financial Officer
|
|
April
6, 2018
|
Richard
B. Slansky
|
|
(Principal
Financial and Accounting Officer)
|
|
|
|
|
|
|
|
/s/
Dr. Avtar Dhillon
|
|
Chairman
of the Board of Directors
|
|
April
6, 2018
|
Dr.
Avtar Dhillon
|
|
|
|
|
|
|
|
|
|
/s/
Dr. James DeMesa
|
|
Director
|
|
April
6, 2018
|
Dr.
James DeMesa
|
|
|
|
|
|
|
|
|
|
/s/
Punit S. Dhillon
|
|
President
and Director
|
|
April
6, 2018
|
Punit
S. Dhillon
|
|
|
|
|
|
|
|
|
|
/s/
Gregory T. Mayes
|
|
Director
|
|
April
6, 2018
|
Gregory
T. Mayes
|
|
|
|
|
EXHIBIT
INDEX
TO
REGISTRATION
STATEMENT ON FORM S-8
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From Mar 2024 to Apr 2024
OncoSec Medical (NASDAQ:ONCS)
Historical Stock Chart
From Apr 2023 to Apr 2024